A NEW IDEA ON BLUEPRINT MEDICINE $BPMC $IBB $XBI $BBH $BIS

This post was just published on ZYX Buy Change Alert.

BPMC is a biotech firm focused on developing cancer treatment therapies.   This is a new IPO.  It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high.

Here is the plan:

Consider buying a 5% tranche in the zone of $22.00 to $23.50. It is trading at $23 as of this writing.  Consider buying a 10% tranche in the zone of $21.00 to $21.67; another 10% tranche in the zone of $20 to $20.37.  10% in the zone of  $19.00 to $19.31 and 20% at $18.00 to $18.57.

Very long-term target zone is $85 to $100.

Here is the plan on stop zones.  15% in the zone of $17.73 to $17.88.  15% in the zone of $16.73 to $16.88.  Mental stop on the remaining 25% under $15.73.

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER